These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33522021)

  • 1. Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck.
    Tam S; Gajera M; Luo X; Glisson BS; Ferrarotto R; Johnson FM; Mott FE; Gillison ML; Lu C; Le X; Blumenschein GR; Wong MK; Rosenthal DI; Nagarajan P; El-Naggar AK; Midgen MR; Weber RS; Myers JN; Gross ND
    Head Neck; 2021 May; 43(5):1592-1603. PubMed ID: 33522021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodal metastasis size predicts disease-free survival in cutaneous head and neck squamous cell carcinoma involving the parotid but not cervical nodes.
    Sood A; Wykes J; McGuinness J; Fowler A; Ebrahimi A
    ANZ J Surg; 2020 Dec; 90(12):2537-2542. PubMed ID: 33176051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
    Machiels JP; Haddad RI; Fayette J; Licitra LF; Tahara M; Vermorken JB; Clement PM; Gauler T; Cupissol D; Grau JJ; Guigay J; Caponigro F; de Castro G; de Souza Viana L; Keilholz U; Del Campo JM; Cong XJ; Ehrnrooth E; Cohen EE;
    Lancet Oncol; 2015 May; 16(5):583-94. PubMed ID: 25892145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of parotidectomy for advanced cutaneous squamous cell carcinoma of the head and neck.
    Kampel L; Dorman A; Horovitz G; Warshavsky A; Gutfeld O; Muhanna N
    Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3955-3963. PubMed ID: 33404750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and Neck Cutaneous Squamous Cell Carcinoma Clinicopathological Risk Factors according to Age and Gender: A Population-based Study.
    Wiser I; Scope A; Azriel D; Zloczower E; Carmel NN; Shalom A
    Isr Med Assoc J; 2016 May; 18(5):275-8. PubMed ID: 27430083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of nodal metastases and prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Sood A; Wykes J; Roshan D; Wang LY; McGuinness J; Forstner D; Fowler A; Lee M; Kernohan M; Ngo Q; Estall V; Ebrahimi A
    ANZ J Surg; 2019 Jul; 89(7-8):863-867. PubMed ID: 30974495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck: Secondary Analysis of a Phase 2 Clinical Trial.
    Ferrarotto R; Nagarajan P; Maronge JM; Johnson JM; Rosenthal DI; Myers JN; Gross ND
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):847-849. PubMed ID: 37535378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
    Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Sood A; Wykes J; Roshan D; Wang LY; McGuinness J; Fowler A; Ebrahimi A
    Head Neck; 2019 Jun; 41(6):1591-1596. PubMed ID: 30659690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma.
    McMullen CP; Ow TJ
    Otolaryngol Clin North Am; 2021 Apr; 54(2):343-355. PubMed ID: 33583597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.
    Laramore GE; Scott CB; Schuller DE; Haselow RE; Ervin TJ; Wheeler R; al-Sarraf M; Gahbauer RA; Jacobs JR; Schwade JG
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1011-6. PubMed ID: 8262821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of advanced cutaneous squamous cell carcinoma lesions on the head and neck successfully treated with nivolumab.
    Ishiguro A; Ogata D; Namikawa K; Takahashi A; Yamazaki N
    J Dermatol; 2021 Sep; 48(9):e434-e435. PubMed ID: 34018639
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent Radiotherapy With Cetuximab or Platinum-based Chemotherapy for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Lu SM; Lien WW
    Am J Clin Oncol; 2018 Jan; 41(1):95-99. PubMed ID: 26353121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of Intraparotid Metastases in Head and Neck Skin Squamous Cell Carcinoma.
    Dür C; Salmina C; Borner U; Giger R; Nisa L
    Laryngoscope; 2021 Apr; 131(4):788-793. PubMed ID: 32918494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural cell adhesion molecule expression: no correlation with perineural invasion in cutaneous squamous cell carcinoma of the head and neck.
    Solares CA; Brown I; Boyle GM; Parsons PG; Panizza B
    Head Neck; 2009 Jun; 31(6):802-6. PubMed ID: 19283849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.
    Sridharan V; Rahman RM; Huang RY; Chau NG; Lorch JH; Uppaluri R; Haddad RI; Hanna GJ; Schoenfeld JD
    Oral Oncol; 2018 Oct; 85():29-34. PubMed ID: 30220316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.